Physician profile
Tri Te
NPI 1447632971
$8,890.87
in general payments reported to CMS, 2019-2025
19 companies · $871 in 2025
The $871 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,944 · 2020: $335 · 2021: $208 · 2022: $477 · 2023: $2,544 · 2024: $2,513 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,137 · Travel and Lodging: $2,503 · Education: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,137.17 |
| Travel and Lodging | $2,503.28 |
| Education | $286.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,930.05 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Penumbra, INC. | $1,636.71 | 2023-2024 | Indigo System |
| Medtronic Vascular, INC. | $1,330.56 | 2019-2020 | |
| Medtronic, INC. | $1,316.30 | 2022-2025 | Onyx Frontier, Symplicity G3 |
| Astrazeneca Pharmaceuticals Lp | $705.30 | 2019-2021 | |
| Boston Scientific Corporation | $575.43 | 2019-2023 | Avvigo Guidance System |
| Abiomed | $570.93 | 2019-2025 | Impella |
| Shockwave Medical, INC | $223.81 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $114.03 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.71 | 2019-2025 | Lifevest |
| Medicomp INC | $82.89 | 2022 | |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $63.21 | 2025 | Camzyos, Eliquis |
| Philips North America LLC | $62.51 | 2025 | Ambulatory Monitoring & Diagnostics Undivided, Extended Holter |
| Novartis Pharmaceuticals Corporation | $37.72 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.81 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.36 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tri Te listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.